Elekta
61.6
SEK
-0.81 %
EKTA B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
11 following
-0.81%
-2.99%
-13.67%
-8.74%
-26.23%
-25.17%
-29.31%
-43.56%
-50.08%
+606.14%
ir.elekta.com/investors
Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.
Revenue
18.12B
EBIT %
11.25 %
P/E
18.06
Dividend yield-%
3.9 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
EKTA B
Daily low / high price
61.3 / 62.2
SEK
Market cap
23.63B SEK
Turnover
14.56M SEK
Volume
236K
Financial calendar
Interim report
2024-11-27
Interim report
2025-02-21
Annual report
2025-05-28
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Fjärde AP-fonden | 9.1 % | 6.7 % |
| Laurent Leksell fam och bolag | 5.7 % | 30.2 % |
| T. Rowe Price | 4.5 % | 3.3 % |
| Nordea funds | 3.8 % | 2.8 % |
| SEB Funds | 3.6 % | 2.7 % |
| Vanguard | 3.4 % | 2.5 % |
| AMF Pension & Fonder | 3.2 % | 2.4 % |
| Handelsbanken Fonder | 3.0 % | 2.2 % |
| Lannebo Kapitalförvaltning AB | 3.0 % | 2.3 % |
| Swedbank Robur Fonder | 2.6 % | 1.9 % |
ShowingAll content types
Invitation to the presentation of Elekta’s second quarter 2024/25
Caroline Leksell Cooke steps down from Elekta's Board of Directors
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools